New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
KARDIGAN INC (KARD) vs Silence Therapeutics PLC Sponsored ADR (SLN)
- KARDIGAN INC KARD 11.54 −7.83%
- Silence Therapeutics PLC Sponsored ADR SLN 19.81 0.00%
KARDIGAN INC and Silence Therapeutics PLC Sponsored ADR are both Biotechnology companies. KARDIGAN INC and Silence Therapeutics PLC Sponsored ADR are of similar size ($1.2B and $1.2B). Across the 9 metrics below, Silence Therapeutics PLC Sponsored ADR leads on 7 and KARDIGAN INC on 2.
Valuation
Profitability
| Metric | KARD | SLN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 79.50% | 70.18% |
| Operating margin | — | (9,345.05%) | 0.00% |
| Net margin | — | (8,943.86%) | 0.00% |
| Free cash flow margin | — | (7,814.66%) | 0.00% |
| Return on equity | (117.38%) | (35.58%) | (51.58%) |
| Return on assets | (80.59%) | (24.01%) | (45.91%) |
| Return on invested capital | (187.24%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack